| Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells C Ma, M Han, B Heinrich, Q Fu, Q Zhang, M Sandhu, D Agdashian, ... Science 360 (6391), eaan5931, 2018 | 1276 | 2018 |
| NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway M Terabe, S Matsui, N Noben-Trauth, H Chen, C Watson, DD Donaldson, ... Nature immunology 1 (6), 515-520, 2000 | 896 | 2000 |
| NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis C Ma, AH Kesarwala, T Eggert, J Medina-Echeverz, DE Kleiner, P Jin, ... Nature 531 (7593), 253-257, 2016 | 700 | 2016 |
| Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte–mediated tumor … M Terabe, S Matsui, JM Park, M Mamura, N Noben-Trauth, DD Donaldson, ... The Journal of experimental medicine 198 (11), 1741-1752, 2003 | 682 | 2003 |
| Progress on new vaccine strategies for the immunotherapy and prevention of cancer JA Berzofsky, M Terabe, SK Oh, IM Belyakov, JD Ahlers, JE Janik, ... The Journal of clinical investigation 113 (11), 1515-1525, 2004 | 451 | 2004 |
| The role of NKT cells in tumor immunity M Terabe, JA Berzofsky Advances in cancer research 101, 277-348, 2008 | 423 | 2008 |
| Immunoregulatory T cells in tumor immunity M Terabe, JA Berzofsky Current opinion in immunology 16 (2), 157-162, 2004 | 415 | 2004 |
| Labeling extracellular vesicles for nanoscale flow cytometry A Morales-Kastresana, B Telford, TA Musich, K McKinnon, C Clayborne, ... Scientific reports 7 (1), 1878, 2017 | 380 | 2017 |
| A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance M Terabe, J Swann, E Ambrosino, P Sinha, S Takaku, Y Hayakawa, ... The Journal of experimental medicine 202 (12), 1627-1633, 2005 | 345 | 2005 |
| Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17 JS Nam, M Terabe, MJ Kang, H Chae, N Voong, Y Yang, A Laurence, ... Cancer research 68 (10), 3915-3923, 2008 | 318 | 2008 |
| An anti–transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments JS Nam, M Terabe, M Mamura, MJ Kang, H Chae, C Stuelten, E Kohn, ... Cancer research 68 (10), 3835-3843, 2008 | 267 | 2008 |
| Cross-regulation between type I and type II NKT cells in regulating tumor immunity: a new immunoregulatory axis E Ambrosino, M Terabe, RC Halder, J Peng, S Takaku, S Miyake, ... The Journal of Immunology 179 (8), 5126-5136, 2007 | 259 | 2007 |
| Role of IL-13 in regulation of anti-tumor immunity and tumor growth M Terabe, JM Park, JA Berzofsky Cancer Immunology, Immunotherapy 53, 79-85, 2004 | 258 | 2004 |
| Progress on new vaccine strategies against chronic viral infections JA Berzofsky, JD Ahlers, J Janik, J Morris, SK Oh, M Terabe, IM Belyakov The Journal of clinical investigation 114 (4), 450-462, 2004 | 225 | 2004 |
| IL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis SK Oh, LP Perera, M Terabe, L Ni, TA Waldmann, JA Berzofsky Proceedings of the National Academy of Sciences 105 (13), 5201-5206, 2008 | 193 | 2008 |
| CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy DR Soto-Pantoja, M Terabe, A Ghosh, LA Ridnour, WG DeGraff, DA Wink, ... Cancer research 74 (23), 6771-6783, 2014 | 191 | 2014 |
| NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis M Terabe, JA Berzofsky Trends in immunology 28 (11), 491-496, 2007 | 190 | 2007 |
| NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis JA Berzofsky, M Terabe The Journal of Immunology 180 (6), 3627-3635, 2008 | 177 | 2008 |
| NKT cell networks in the regulation of tumor immunity FC Robertson, JA Berzofsky, M Terabe Frontiers in immunology 5, 543, 2014 | 159 | 2014 |
| Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody M Terabe, E Ambrosino, S Takaku, JJ O'Konek, D Venzon, S Lonning, ... Clinical Cancer Research 15 (21), 6560-6569, 2009 | 147 | 2009 |